Imexpharm (STC:IMP) Cash Flow for Dividends : ₫0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Imexpharm Cash Flow for Dividends?

Imexpharm's cash flow for dividends for the three months ended in Mar. 2024 was ₫0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ₫0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Imexpharm's annual payment of dividends stayed the same from Dec. 2021 (₫-100,007 Mil) to Dec. 2022 (₫-100,007 Mil) but then declined from Dec. 2022 (₫-100,007 Mil) to Dec. 2023 (₫-66,672 Mil).

Imexpharm Cash Flow for Dividends Historical Data

The historical data trend for Imexpharm's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imexpharm Cash Flow for Dividends Chart

Imexpharm Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-98,802.72

-49,387.36

-100,007.36

-66,671.57

Imexpharm Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Imexpharm Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0 Mil.

Imexpharm Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Imexpharm's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Imexpharm (STC:IMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Imexpharm Corp (STC:IMP) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM

Website

http://www.imexpharm.com

Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. Its products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.

Imexpharm (STC:IMP) Headlines

No Headlines